Sprint Bioscience AB (publ) (STO: SPRINT)
1.240
0.00 (0.00%)
Sep 11, 2024, 5:00 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 86.58 million as of September 12, 2024. Its market cap has increased by 4.20% in one year.
Market Cap
86.58M
Enterprise Value
50.57M
Revenue
86.21M
Ranking
n/a
PE Ratio
5.88
Stock Price
1.24
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 86.58M, an increase of 38.54%. That is a compound annual growth rate of 3.36%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 2,609.07B |
Swedish Orphan Biovitrum AB (publ) | 108.72B |
Getinge AB (publ) | 59.98B |
Camurus AB (publ) | 40.64B |
Vitrolife AB (publ) | 35.04B |
Medicover AB (publ) | 29.01B |
Elekta AB (publ) | 24.26B |
Vimian Group AB (publ) | 23.51B |